156 related articles for article (PubMed ID: 7645981)
41. Influence of microenvironmental pH on adriamycin resistance.
Alabaster O; Woods T; Ortiz-Sanchez V; Jahangeer S
Cancer Res; 1989 Oct; 49(20):5638-43. PubMed ID: 2790781
[TBL] [Abstract][Full Text] [Related]
42. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
[TBL] [Abstract][Full Text] [Related]
43. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Nov; 42(11):4730-3. PubMed ID: 7127307
[TBL] [Abstract][Full Text] [Related]
44. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
Nair S; Horton A; Leif RC; Krishan A
Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
[TBL] [Abstract][Full Text] [Related]
45. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
Krishan A; Sauerteig A; Gordon K; Swinkin C
Cancer Res; 1986 Apr; 46(4 Pt 1):1768-73. PubMed ID: 3948163
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D
Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
[TBL] [Abstract][Full Text] [Related]
47. Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.
Yanovich S; Preston L
Cancer Res; 1984 May; 44(5):1743-7. PubMed ID: 6713377
[TBL] [Abstract][Full Text] [Related]
48. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
[TBL] [Abstract][Full Text] [Related]
49. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Rouse W; Riegler F
Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
[TBL] [Abstract][Full Text] [Related]
50. Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance.
Frey T; Yue S; Haugland RP
Cytometry; 1995 Jul; 20(3):218-27. PubMed ID: 7587707
[TBL] [Abstract][Full Text] [Related]
51. [Effects of calcium influx blocker on the cellular transport of Adriamycin].
Sasaki K; Nagaoka S; Murakami T; Kawasaki S; Takahashi M
Gan To Kagaku Ryoho; 1985 Apr; 12(4):966-8. PubMed ID: 4039125
[TBL] [Abstract][Full Text] [Related]
52. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
Ganapathi R; Reiter W; Krishan A
J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
[TBL] [Abstract][Full Text] [Related]
53. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
Ramu A; Glaubiger D; Fuks Z
Cancer Res; 1984 Oct; 44(10):4392-5. PubMed ID: 6467200
[TBL] [Abstract][Full Text] [Related]
54. Characterization of multidrug resistance by fluorescent dyes.
Kessel D; Beck WT; Kukuruga D; Schulz V
Cancer Res; 1991 Sep; 51(17):4665-70. PubMed ID: 1873811
[TBL] [Abstract][Full Text] [Related]
55. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
Ramu A; Shan TC; Glaubiger D
Cancer Treat Rep; 1983 Oct; 67(10):895-9. PubMed ID: 6354437
[TBL] [Abstract][Full Text] [Related]
56. [The effect of finoptin on the accumulation of doxorubicin in leukemia P388 cells with induced resistance to the antibiotic].
Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
Biull Eksp Biol Med; 1989 Dec; 108(12):714-6. PubMed ID: 2634447
[TBL] [Abstract][Full Text] [Related]
57. Doxorubicin resistance circumvention by verapamil in B16 melanoma cells.
Mariani M; Prosperi E; Colombo A; Supino R
Anticancer Res; 1989; 9(1):29-32. PubMed ID: 2705752
[TBL] [Abstract][Full Text] [Related]
58. Sensitivity to anthracyclines in P388/dx leukaemia cells.
Bossa R; Dasdia T; Galatulas I; Zunino F
Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
[TBL] [Abstract][Full Text] [Related]
59. The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin-resistant and -sensitive leukemia in vitro and in vivo.
Radel S; Bankusli I; Mayhew E; Rustum YM
Cancer Chemother Pharmacol; 1988; 21(1):25-30. PubMed ID: 3342462
[TBL] [Abstract][Full Text] [Related]
60. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
Nair S; Samy TS; Krishan A
Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
